 Misoprostol
"Misoprostol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties.
| Descriptor ID |
D016595
|
| MeSH Number(s) |
D10.251.355.255.550.775.450.500 D23.469.050.175.725.775.450.500 D23.469.700.660.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Misoprostol".
Below are MeSH descriptors whose meaning is more specific than "Misoprostol".
This graph shows the total number of publications written about "Misoprostol" by people in this website by year, and whether "Misoprostol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 2002 | 1 | 0 | 1 | | 2003 | 1 | 0 | 1 | | 2009 | 2 | 1 | 3 | | 2010 | 1 | 0 | 1 | | 2011 | 0 | 1 | 1 | | 2014 | 1 | 0 | 1 | | 2015 | 1 | 0 | 1 | | 2016 | 1 | 0 | 1 | | 2020 | 2 | 0 | 2 | | 2021 | 1 | 0 | 1 | | 2022 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Misoprostol" by people in Profiles.
-
Munger MA, Nelson SD, Teng CC, Cheung AK, Sauer BC. Reduced risk of NSAID-Induced adverse events with concomitant use of misoprostol (MICRO study). Pharmacotherapy. 2022 07; 42(7):540-548.
-
Roe AH, Abernathy A, Flynn AN, McAllister A, Koelper NC, Sammel MD, Schreiber CA, Sonalkar S. Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss. Obstet Gynecol. 2022 06 01; 139(6):1149-1151.
-
Peterson SF, Lerma K, Shaw KA, Blumenthal PD. Cervical Preparation Using Ulipristal Acetate With Adjunct Misoprostol in Second-Trimester Surgical Abortions. Obstet Gynecol. 2022 05 01; 139(5):907-909.
-
Flynn AN, Roe AH, Koelper N, McAllister A, Sammel MD, Schreiber CA. Timing and efficacy of mifepristone pretreatment for medical management of early pregnancy loss. Contraception. 2021 06; 103(6):404-407.
-
Sonalkar S, Koelper N, Creinin MD, Atrio JM, Sammel MD, McAllister A, Schreiber CA. Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial. Am J Obstet Gynecol. 2020 10; 223(4):551.e1-551.e7.
-
Fang NZ, Guiahi M, Lazorwitz A. Satisfaction with medication abortion and marijuana use: A prospective cohort study. Contraception. 2020 07; 102(1):30-33.
-
Raymond EG, Harrison MS, Weaver MA. Efficacy of Misoprostol Alone for First-Trimester Medical Abortion: A Systematic Review. Obstet Gynecol. 2019 01; 133(1):137-147.
-
Levine LD, Downes KL, Elovitz MA, Parry S, Sammel MD, Srinivas SK. Mechanical and Pharmacologic Methods of Labor Induction: A Randomized Controlled Trial. Obstet Gynecol. 2016 12; 128(6):1357-1364.
-
Schreiber CA, Ratcliffe SJ, Quinley KE, Miller C, Sammel MD. Serum biomarkers may help predict successful misoprostol management of early pregnancy failure. Reprod Biol. 2015 Jun; 15(2):79-85.
-
Goldthwaite LM, Teal SB. Controversies in family planning: pregnancy termination in women with uterine anatomic abnormalities. Contraception. 2014 Oct; 90(4):460-3.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|